HOME > BUSINESS
BUSINESS
- Shonan iPark Kicks Off Demonstration Experiment Seeking “Mibyo” Business Opportunities
September 9, 2019
- Meiji Seika’s Schizophrenia Treatment ME2112 Misses Primary Goal in Japan PIII Study
September 9, 2019
- EA Pharma Obtains Global Rights for Glycolipid Compound from National Neurology Center
September 9, 2019
- Takeda Launches US Recall of Natpara Parathyroid Hormone
September 9, 2019
- Lonsurf Gets European Nod for Gastric Cancer
September 9, 2019
- To Counter Latuda Patent Cliff, Sumitomo Dainippon Poised to Buy 5 “Vants” Companies from Roivant
September 9, 2019
- Labor Union Urges MSD Japan to Make Convincing Case on Job Cuts
September 6, 2019
- MHLW Lifts All-Case PMS Requirement for Pfizer’s Xeljanz for RA Treatment
September 6, 2019
- Keytruda Continues to Enjoy Top Title in August Sales Ranking: Encise
September 6, 2019
- Japan Pharma Market Likely to Shrivel 0.7% Annually in Next 5 Years: IQVIA
September 5, 2019
- Roche/Chugai’s Rozlytrek, AstraZeneca COPD Combos and More Hit Shelves
September 5, 2019
- Anges, Mitsubishi Tanabe to Launch Gene Therapy Collategene on Sept. 10
September 5, 2019
- Candesartan Generics OK'ed for Pediatric Use, Now Offer Full Indications
September 5, 2019
- Edoxaban/Clopidogrel Combo Shows Non-Inferiority against Warfarin Triplet in AF: Daiichi Sankyo
September 5, 2019
- 1st Schizophrenia Patch Drug to Hit Japan Market on Sept. 10: Sumitomo Dainippon
September 4, 2019
- Latuda Makes Debut in China: Sumitomo Dainippon
September 4, 2019
- 70% of Japanese ACS Patients Fail to Hit LDL-C Management Goal in Observational Study: Sanofi
September 4, 2019
- Keytruda Boon Aside, MSD Japan Mulls Job Cuts for Sales and Marketing
September 4, 2019
- Higher Rate of Resistance to Xofluza Seen in Younger Children: Shionogi
September 3, 2019
- Astellas Grabs Global Rights to RIKEN’s aAVC Technology in Oncology
September 3, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
